Genetic screens and functional genomics using CRISPR/Cas9 technology

The FEBS Journal
Ella Hartenian, John G Doench

Abstract

Functional genomics attempts to understand the genome by perturbing the flow of information from DNA to RNA to protein, in order to learn how gene dysfunction leads to disease. CRISPR/Cas9 technology is the newest tool in the geneticist's toolbox, allowing researchers to edit DNA with unprecedented ease, speed and accuracy, and representing a novel means to perform genome-wide genetic screens to discover gene function. In this review, we first summarize the discovery and characterization of CRISPR/Cas9, and then compare it to other genome engineering technologies. We discuss its initial use in screening applications, with a focus on optimizing on-target activity and minimizing off-target effects. Finally, we comment on future challenges and opportunities afforded by this technology.

References

Apr 16, 2002·Molecular Microbiology·Ruud JansenLeo M Schouls
Feb 26, 2003·Genes & Development·John G DoenchPhillip A Sharp
May 20, 2003·Nature Biotechnology·Aimee L JacksonPeter S Linsley
Mar 29, 2005·Journal of Molecular Evolution·Francisco J M MojicaElena Soria
Jun 18, 2005·Cell·Thomas F WestbrookStephen J Elledge
Sep 23, 2006·Nature Methods·Christophe J EcheverriRené Bernards
Mar 24, 2007·Science·Rodolphe BarrangouPhilippe Horvath
Dec 25, 2007·Cell Research·Meena ShrivastavJac A Nickoloff
Aug 16, 2008·Science·Stan J J BrounsJohn van der Oost
Dec 19, 2008·Proceedings of the National Academy of Sciences of the United States of America·Biao LuoDavid E Root
Aug 10, 2010·Annual Review of Genetics·Wolf-Dietrich HeyerJie Liu
Nov 5, 2010·Nature·Josiane E GarneauSylvain Moineau
Dec 15, 2010·ACS Chemical Biology·Frederic D Sigoillot, Randall W King
Apr 2, 2011·Nature·Elitza DeltchevaEmmanuelle Charpentier
May 10, 2011·Nature Reviews. Microbiology·Kira S MakarovaEugene V Koonin
Jul 13, 2011·Proceedings of the National Academy of Sciences of the United States of America·Hiu Wing CheungWilliam C Hahn
Aug 5, 2011·Nucleic Acids Research·Rimantas SapranauskasVirginijus Siksnys
Feb 22, 2012·Nature Methods·Frederic D SigoillotRandall W King
May 31, 2012·Scientific Reports·Eugen BuehlerMarc Ferrer
Jun 30, 2012·Science·Martin JinekEmmanuelle Charpentier
Sep 6, 2012·Proceedings of the National Academy of Sciences of the United States of America·Giedrius GasiunasVirginijus Siksnys
Sep 8, 2012·Nature·UNKNOWN ENCODE Project Consortium
Jan 5, 2013·Science·Le CongFeng Zhang
Jan 5, 2013·Science·Prashant MaliGeorge M Church
Jan 5, 2013·Cancer Discovery·Steven R WhittakerLevi A Garraway
Feb 7, 2013·ELife·Martin JinekJennifer Doudna
Jun 25, 2013·Nature Biotechnology·Yanfang FuJeffry D Sander
Jul 23, 2013·Nature Biotechnology·Patrick D HsuFeng Zhang
Aug 3, 2013·Nucleic Acids Research·Luhan YangGeorge Church
Oct 1, 2013·Nature Methods·Kevin M EsveltGeorge M Church
Dec 18, 2013·Science·Tim WangEric S Lander
Dec 18, 2013·Science·Ophir ShalemFeng Zhang
Jan 28, 2014·Nature Biotechnology·Yanfang FuJ Keith Joung
Jan 31, 2014·Nature·Samuel H SternbergJennifer A Doudna
Feb 18, 2014·Cell·Hiroshi NishimasuOsamu Nureki

❮ Previous
Next ❯

Citations

Jan 19, 2016·Nature Biotechnology·John G DoenchDavid E Root
Dec 15, 2015·The FEBS Journal·Seamus J Martin
Mar 15, 2016·Expert Opinion on Drug Discovery·Ivan Fraietta, Fabio Gasparri
Jul 26, 2015·Journal of Cell Communication and Signaling·Herman Yeger
Jun 3, 2016·Nucleosides, Nucleotides & Nucleic Acids·Hiroyuki KamiyaHideyoshi Harashima
Jun 23, 2016·Briefings in Functional Genomics·Xiaolong QiGuoxin Li
Jul 16, 2016·Trends in Biotechnology·Guo-Hui ChuaiQi Liu
Aug 2, 2016·Biological & Pharmaceutical Bulletin·Tetsuya SuzukiHiroyuki Kamiya
Jun 9, 2016·The FEBS Journal·Stephanie E MohrNorbert Perrimon
Nov 1, 2016·Nature Reviews. Genetics·Benjamin E HousdenNorbert Perrimon
Dec 21, 2016·The FEBS Journal·Emily J Chenette
May 10, 2017·Nucleosides, Nucleotides & Nucleic Acids·Tetsuya SuzukiHiroyuki Kamiya
Jun 8, 2017·Journal of Cellular Biochemistry·Jiachen LinNan Wu
Feb 18, 2018·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Rout George KerryJyoti Ranjan Rout
Feb 2, 2018·Viruses·Makda GebreBenjamin E Gewurz
Nov 22, 2017·Scientific Reports·Philipp N SpahnOlivier Harismendy
Feb 13, 2019·Journal of Inherited Metabolic Disease·Alfonso León-Del-Río
May 10, 2019·Nature Communications·Hagar MeltzerOren Schuldiner
Dec 5, 2017·Nature Reviews. Genetics·John G Doench
May 19, 2019·RNA·Megan D SchertzerJ Mauro Calabrese
Jan 18, 2018·Current Protocols in Molecular Biology·Federica PiccioniDavid E Root
Aug 25, 2016·Oncotarget·Dandan YuZhenhe Suo
Apr 6, 2016·Menopause : the Journal of the North American Menopause Society·Patsama Vichinsartvichai
Jul 31, 2020·Nucleosides, Nucleotides & Nucleic Acids·Hidehiko KawaiHiroyuki Kamiya
Apr 1, 2015·The FEBS Journal·Liana Tsiatsiani, Albert J R Heck
Sep 10, 2017·The FEBS Journal·Yoshihisa Matsumoto
Aug 30, 2019·PLoS Computational Biology·Jacob Bradford, Dimitri Perrin
Dec 26, 2019·BMC Genomics·Jacob Bradford, Dimitri Perrin
Jun 15, 2017·Wellcome Open Research·María Rodríguez-LópezJürg Bähler
Jan 6, 2018·Genetics·Ethan BierJill Wildonger

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR Screens in Drug Resistance (ASM)

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR Genome Editing & Therapy

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of this system for gene editing and therapy in human diseases.

© 2022 Meta ULC. All rights reserved